Tatsuyuki Naruchi

This inventor holds 6 USPTO granted patents. Top assignees: Teijin Limited, Teijin Pharmaceutical Co., Ltd.. Active years: 1982-1993.

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 42(Granted Patents)

Company Filing History:

Teijin Pharmaceutical Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 1982-1993

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5229422 - Extemporaneous preparation type kit of a pharmaceutical (1993-07-20),

2. 4472428 - Halogenated prostacyclins pharmaceutical use thereof and hydroxy (1984-09-18),

3. 4421914 - Thiazolo[3,2-a]pyrimidines, derivatives thereof, processes for (1983-12-20),

4. 4402975 - Aminocarboxylic acids, amino alcohols, or the derivatives thereof, (1983-09-06),

5. 4383996 - Derivative of thiazolo[3,2-a]pyrimidine and a process for the (1983-05-17),

6. 4364941 - Method for regulating bone metabolism of warm-blooded animals, and (1982-12-21),

Title: Innovations of Tatsuyuki Naruchi

Introduction

Tatsuyuki Naruchi is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel halogenated prostacyclins. With a total of 6 patents to his name, Naruchi's work has had a substantial impact on vascular actions and organ transplantation.

Latest Patents

Naruchi's latest patents include an extemporaneous preparation type kit of a pharmaceutical, as well as halogenated prostacyclins for pharmaceutical use. His innovations focus on novel 5- or 7-monohalogenated or 5,7-dihalogenated compounds, which are essential for controlling vascular actions and are applicable in organ transplantation and extra-corporeal circulation. The processes he developed for preparing these halogenated prostacyclins are groundbreaking in the pharmaceutical industry.

Career Highlights

Throughout his career, Tatsuyuki Naruchi has worked with notable companies such as Teijin Limited and Teijin Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in pharmaceutical technology.

Collaborations

Naruchi has collaborated with esteemed colleagues, including Kiyoshi Bannai and Takeo Oba. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Tatsuyuki Naruchi's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence advancements in medical science and technology.